Sarepta Therapeutics, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sarepta Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Sarepta Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 11.8 %.
  • Sarepta Therapeutics, Inc. annual Return On Equity for 2023 was -69.7 %, a 40.6% increase from 2022.
  • Sarepta Therapeutics, Inc. annual Return On Equity for 2022 was -117 %, a 69.3% decline from 2021.
  • Sarepta Therapeutics, Inc. annual Return On Equity for 2021 was -69.3 %, a 20.1% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -69.7 +47.6 +40.6% Jan 1, 2023 Dec 31, 2023
2022 -117 -48 -69.3% Jan 1, 2022 Dec 31, 2022
2021 -69.3 -11.6 -20.1% Jan 1, 2021 Dec 31, 2021
2020 -57.7 +9.43 +14% Jan 1, 2020 Dec 31, 2020
2019 -67.1 -21.1 -46% Jan 1, 2019 Dec 31, 2019
2018 -46 -37.2 -420% Jan 1, 2018 Dec 31, 2018
2017 -8.84 +97.5 +91.7% Jan 1, 2017 Dec 31, 2017
2016 -106 +23.2 +17.9% Jan 1, 2016 Dec 31, 2016
2015 -129 -78.4 -153% Jan 1, 2015 Dec 31, 2015
2014 -51.1 +15.7 +23.5% Jan 1, 2014 Dec 31, 2014
2013 -66.8 +245 +78.6% Jan 1, 2013 Dec 31, 2013
2012 -312 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.